OFI Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

OFI Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$19K	Sell	212 -25	-11%	-$2.64K	﹤0.01%	1665
2015 Q2	$27K	Buy	+237	New	+$24.9K	﹤0.01%	1649
2014 Q4	–	Sell	-318	Closed	-$17K	–	1743
2014 Q3	$17K	Buy	318 +61	+24%	+$3K	﹤0.01%	1686
2014 Q2	$11K	Buy	257 +38	+17%	+$1.55K	﹤0.01%	1667
2014 Q1	$8K	Buy	219 +11	+5%	+$350	﹤0.01%	1688
2013 Q4	$6K	Sell	208 -8	-4%	-$232	﹤0.01%	1709
2013 Q3	$6K	Buy	216 +26	+14%	+$648	﹤0.01%	1709
2013 Q2	$4K	Buy	+190	New	+$4.79K	﹤0.01%	1712

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OFI Advisors's CBPO Position: Q3 2015 in Review

OFI Advisors reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 11% in Q3 2015, selling an estimated $2.64K and leaving 212 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

OFI Advisors first reported a position in CBPO in Q2 2013 and has held it in 8 quarters since. The position peaked at $27K in Q2 2015. 106 funds tracked by Wall St. Rank hold CBPO as of Q3 2015.

OFI Advisors held 212 shares of China Biologic Products Holdings, Inc. worth $19K as of Q3 2015.
OFI Advisors sold 25 China Biologic Products Holdings, Inc. shares in Q3 2015, an estimated $2.64K.
China Biologic Products Holdings, Inc. made up ﹤0.01% of OFI Advisors's portfolio in Q3 2015, its #1665 holding.
OFI Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and has held it in 8 quarters since.
OFI Advisors's China Biologic Products Holdings, Inc. position peaked at $27K in Q2 2015.
106 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.